Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
10.80
-0.56 (-4.93%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Elicio Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 199 | 139 | 55 | 80 | - | - | |
| Market Cap Growth | 145.85% | 153.09% | -31.39% | - | - | - | |
| Enterprise Value | 195 | 134 | 55 | 72 | - | - | |
| Last Close Price | 10.80 | 7.96 | 5.10 | 8.34 | - | - | |
| PB Ratio | 117.51 | 85.03 | -4.86 | 7.04 | - | - | |
| P/TBV Ratio | 121.44 | 85.03 | - | 7.04 | - | - | |
| Debt / Equity Ratio | 8.87 | 8.87 | -2.30 | 0.61 | 0.84 | -2.88 | |
| Net Debt / Equity Ratio | -2.48 | -2.48 | -0.74 | -0.53 | 0.15 | -0.61 | |
| Net Debt / EBITDA Ratio | 0.11 | 0.11 | -0.19 | 0.17 | -0.06 | -0.10 | |
| Net Debt / FCF Ratio | 0.11 | 0.11 | -0.23 | 0.18 | -0.06 | -0.10 | |
| Quick Ratio | 2.29 | 2.29 | 1.53 | 1.32 | 0.90 | 0.49 | |
| Current Ratio | 2.38 | 2.38 | 1.80 | 1.68 | 1.56 | 0.55 | |
| Return on Equity (ROE) | - | - | -170157.38% | -346.95% | -1170.93% | -430.76% | |
| Return on Assets (ROA) | -87.24% | -87.24% | -101.64% | -89.70% | -79.16% | -92.36% | |
| Return on Capital Employed (ROCE) | -212.40% | -212.40% | -270.10% | -205.50% | -150.20% | 626.30% | |
| Earnings Yield | -19.92% | -28.45% | -94.42% | -43.93% | - | - | |
| FCF Yield | -18.61% | -26.58% | -67.60% | -40.89% | - | - | |
| Buyback Yield / Dilution | -25.48% | -25.48% | -141.35% | -1500.08% | 97.93% | -42.39% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.